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Oncostatin M regulates membrane traffic and stimulates apicalization of the cell surface in hepatoma cells in a protein
kinase A-dependent manner. Here, we show that oncostatin M enhances the expression of the cyclin-dependent kinase
(cdk)2 inhibitor p27Kip1, which inhibits G1-S phase progression. Forced G1-S-phase transition effectively renders presyn-
chronized cells insensitive to the apicalization-stimulating effect of oncostatin M. G1-S-phase transition prevents oncosta-
tin M-mediated recruitment of protein kinase A to the centrosomal region and precludes the oncostatin M-mediated
activation of a protein kinase A-dependent transport route to the apical surface, which exits the subapical compartment
(SAC). This transport route has previously been shown to be crucial for apical plasma membrane biogenesis. Together,
our data indicate that oncostatin M-stimulated apicalization of the cell surface is critically dependent on the ability of
oncostatin M to control p27Kip1/cdk2-mediated G1-S-phase progression and suggest that the regulation of apical plasma
membrane-directed traffic from SAC is coupled to centrosome-associated signaling pathways.
INTRODUCTION
The establishment and maintenance of apical and basolat-
eral plasma membrane (PM) domains in epithelia require a
careful orchestration of extra- and intracellular signals, trig-
gering crucial cytoskeleton-, organelle-, and membrane traf-
fic-linked machineries, as partly elucidated in systems as
diverse as yeast, Drosophila, and mammalian cells (Lecuit
and Pilot, 2003; Mostov et al., 2003; Baas et al., 2004). Impair-
ment of these events may cause a loss of apical-basolateral
asymmetry and may lead to deranged cell growth (Bilder et
al., 2000; Vermeer et al., 2003; Baas et al., 2004) or spindle
misorientation (Albertson and Doe, 2003). Recent studies
have reported an evolutionary conserved genetic program
that may link the process of polarity development and pro-
liferation (Bilder et al., 2000; Humbert et al., 2003; Rolls et al.,
2003; Klezovitch et al., 2004). However, many aspects of such
a link remain unclear, e.g., the extent to which cell prolifer-
ation can directly affect epithelial cell organization or vice
versa. Indeed, epithelial cell proliferation and apical-baso-
lateral polarity may be controlled by different signaling
pathways (Liu et al., 2004).
Signaling cascades stimulated by interleukin-6 family cy-
tokines, including oncostatin M (OSM), elicit multiple re-
sponses in the cell. Originally, as its name indicates, oncosta-
tin M was primarily recognized to inhibit the proliferation of
tumor cells (Tanaka and Miyajima, 2003), presumably by
modulating cell cycle regulatory proteins, including the cy-
clin-dependent kinase (cdk)2-inhibitor p27Kip1 (Kortylewski
et al., 1999; Klausen et al., 2000; Li et al., 2001). Disruption of
the regulatory system that controls G1-phase progression is
a common event in human hepatocarcinogenesis (Hui et al.,
1998), and p27Kip1 has been associated with differentiation,
invasiveness, and metastasis of hepatocellular carcinoma
tumors (Zhou et al., 2003). Recent evidence indicate that
OSM signaling plays a prominent role in liver development
(Kamiya et al., 1999, 2001, 2002; Kojima et al., 2000; Kinoshita
and Miyajima, 2002; Matsui et al., 2002; Chagraoui et al.,
2003; Hanada et al., 2003; Lazaro et al., 2003). OSM stimulates
hepatocyte nuclear factor-4 (Kamiya et al., 2003), which may
integrate the genetic programs of liver-specific gene expres-
sion and epithelial morphogenesis (Spath and Weiss, 1998).
In addition, OSM induces adherens junction formation by
altering the subcellular localization of adherens junction
components, including E-cadherin and catenins (Matsui et
al., 2002). In human fetal hepatocytes as well as in well-
differentiated human hepatic HepG2 cells, OSM stimulates
the development of apical bile canalicular plasma mem-
brane (PM) domains (Lazaro et al., 2003; van der Wouden et
al., 2002), which requires the activation of a gp130-mediated
signaling cascade and endogenous protein kinase A (PKA)
activity (van der Wouden et al., 2002). Although the molec-
ular mechanisms that underlie apicalization of the cell sur-
face in hepatocytes are poorly understood, the de novo
reorganization of the lateral PM after the establishment of
E-cadherin–dependent cell-cell adhesion, mediated by cy-
toskeleton rearrangements and the polarized sorting and
trafficking of proteins and lipids, plays a crucial role.
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Apical protein and lipid sorting in polarized hepatocytes
occurs in the Golgi apparatus and the subapical compart-
ment (SAC; the hepatocyte equivalent of the pericentroso-
mal recycling endosomes in other epithelia). In the Golgi
apparatus, newly synthesized proteins and lipids destined
for the apical surface are sorted into sphingolipid-cholester-
ol–enriched membrane microdomains (rafts). Thus, in the
trans-Golgi network, multimembrane-spanning or polytopic
apical membrane proteins are clustered in Lubrol WX-resis-
tant membrane domains and delivered via vesicular trans-
port directly to the apical surface (Aı¨t Slimane et al., 2003).
Single membrane-spanning apical proteins are segregated in
other, Triton X-100–resistant membrane domains and tar-
geted first to the basolateral surface, followed by their trans-
port to the apical domain by transcytosis (Aı¨t Slimane et al.,
2003; Nyasae et al., 2003; Tuma and Hubbard, 2003). After
surface delivery extensive membrane exchange occurs be-
tween the apical and basolateral domains, which involves
endocytosis and subsequent recycling to either PM domain.
The SAC plays a prominent role in the polarized delivery of
proteins and lipids, and thus in maintaining cell surface
polarity (Ihrke et al., 1998; van IJzendoorn and Hoekstra,
1999a,b; Rahner et al., 2000; van IJzendoorn and Mostov,
2000). Moreover, polarized membrane traffic from SAC is
also important for the de novo biogenesis of apical PM
domains (van IJzendoorn and Hoekstra, 2000), triggered by
extracellular stimuli, including OSM (van der Wouden et al.,
2002) and those that elicit cAMP/PKA signaling cascades
(Zegers and Hoekstra, 1997). Indeed, we have previously
shown that OSM activates a vesicular membrane trafficking
pathway from SAC to the apical PM, which is dependent on
cAMP/PKA activity (van der Wouden et al., 2002). Impor-
tantly, activation of this OSM-cAMP/PKA–regulated path-
way is crucial for apical PM biogenesis in HepG2 cells (van
der Wouden et al., 2002).
The pronounced effects of OSM on cell cycle progression,
membrane traffic, and cell polarity prompted us to investi-
gate the functional relationship between these events to
obtain better insight into molecular mechanisms that control
the establishment of apical surface domains in conjunction
with cell cycle control.
MATERIALS AND METHODS
Cell Culture
HepG2 cells were grown in DMEM with 4500 mg of glucose per liter,
containing 10% fetal calf serum and antibiotics. Media were changed every
other day. Cells were trypsinized after reaching confluence. For experiments,
cells were plated at low density onto ethanol-sterilized coverslips and ana-
lyzed 24, 48, 72, or 76 h after plating.
To synchronize cells in the G1 phase of the cell cycle, cells were first grown
in normal culture medium for 36 h to allow expansion of the cells, followed
by culture in serum-free medium for 36 h. In some experiments, cells were
subsequently exposed to normal culture medium containing 10% fetal calf
serum (FCS) or cultured in medium supplemented with 30 M fumonisin B1
(Sigma-Aldrich, St. Louis, MO; see Results), to chase the cells from G1 into the
S phase. As a control, cells were chased in serum-free medium. G1-S-phase
transition was monitored by the initiation of DNA synthesis, as evidenced by
bromodeoxyuridine (BrdU) incorporation (Figures 2C and 3C). In other ex-
periments, cells were first grown in normal culture medium for 36 h, followed
by culturing in normal medium supplemented with the DNA synthesis
inhibitor hydroxyurea (4 mM; Sigma-Aldrich) to synchronize the cells in S
phase.
Determination of HepG2 Cell Polarity
Accurate estimation of the degree of HepG2 polarity was performed as
described previously (Zegers and Hoekstra, 1997; van IJzendoorn and Hoek-
stra, 2000). Briefly, the cells were fixed with 20°C ethanol for 10 s, rehy-
drated in Hank’s balanced slat solution (HBSS), and subsequently incubated
with a mixture of tetramethylrhodamine B isothiocyanate-labeled phalloidin
(Molecular Probes, Eugene, OR) and 5 ng/ml the nuclear stain Hoechst 33528
(Sigma-Aldrich) at room temperature for 30 min. The cells were then washed,
and the number of bile canaliculi (BC; identified by the presence of dense
F-actin staining around the BC) per 100 cells (identified by fluorescently
labeled nuclei) was determined and expressed as the ratio [BC/100 cells]. Ten
fields (each containing 50 cells) per coverslip (at least two coverslips per
condition were studied) were analyzed. Cells were examined using an epi-
fluorescence microscope (Provis AX70; Olympus, New Hyde Park, NY).
Immunostaining of HepG2 Cells
HepG2 cells were fixed in 4% paraformaldehyde (PFA) for 30 min at room
temperature, washed, and permeabilized for 10 min with methanol at 20°C.
After blocking with 1% bovine serum albumin (BSA) in phosphate-buffered
saline (37°C; 1 h) the cells were incubated with primary antibody for 1 h at
37°C. For immunofluorescent costaining of -tubulin and PKA, cells were first
incubated with 0.5% Triton X-100 at 4°C for 3 min, followed by fixation with
ice-cold (20°C) methanol for 5 min and blocking with 1% BSA. Monoclonal
anti-p27Kip1 and anti-PKA-RII antibodies were bought from BD Transduc-
tion Laboratories (Lexington, KY) and used at 1:300 dilution. After incubation
with the primary antibodies, cells were washed and incubated with the
corresponding secondary antibody labeled with Alexa Fluor488 or Alexa
Fluor594 (Molecular Probes) for 30 min at room temperature. The coverslips
were mounted and analyzed by confocal microscopy (TCS SP2; Leica, Wet-
zlar, Germany).
BrdU Incorporation Assay
HepG2 cells were incubated with 50 mM BrdU in normal culture medium (see
Results). Cells were then washed with HBBS and fixed with 4% PFA at room
temperature for 30 min. Cells were subsequently washed with HBBS and
incubated in 2 N HCl for 1 h. Cells were processed for immunofluorescence
microscopy as described above. In brief, cells were incubated at 37°C for 30
min with a mouse monoclonal antibody against BrdU (1:50 dilution; Chemi-
con International, Temecula, CA). As secondary antibody, Alexa488 goat
anti-mouse IgG was used (Molecular Probes). During the secondary antibody
incubation, 5 ng/ml nuclear stain Hoechst 33528 was included to visualize the
nuclei. The cells were then rinsed four times with HBBS, mounted, and
examined by fluorescence microscopy as described above. The percentage of
cells that had incorporated BrdU was quantified by determining the ratio of
BrdU-positive nuclei. At least 10 fields each containing 50 cells were
counted.
Analysis of p27Kip1 Levels by Western Blot
HepG2 cells were treated as described in Results and then lysed in 0.5 ml of
Triton X-100 lysis buffer (10 mM triethanolamine, pH 7.4, 1.0% Triton X-100,
0.1% SDS, 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF, 20 mM
Na4P2O7, and 2 mM sodium vanadate and a cocktail of protease inhibitors).
Lysates were boiled for 5 min and cleared by centrifugation. Protein concen-
trations were determined by a bicinchoninic acid protein assay (Sigma-Al-
drich), and equal amounts of proteins were separated on 10% SDS-PAGE gels,
immunoblotted with monoclonal p27Kip1 antibodies (BD Transduction Labo-
ratories) and detected with an enhanced chemiluminescence system (Amer-
sham Biosciences, Piscataway, NJ). Bands representing p27Kip1 were quanti-
fied using Scion Image software.
Analysis of Transport of C6-NBD-GalCer from SAC
To study the trafficking of the fluorescent GalCer analog from SAC, SAC were
preloaded with the lipid as depicted in Figure 1. This procedure has been
described in detail previously (van IJzendoorn and Hoekstra, 1999a, 2000). In
short, cells were labeled with 4 M C6-NBD-GalCer at 37°C (Figure 1, step 1)
to allow internalization from the basolateral surface and subsequent transcy-
tosis to the apical BC PM domain (Figure 1, step 2). After 30 min of incubation,
lipid analog still residing at the basolateral domain was depleted by a back
exchange procedure at 4°C [2  30 min incubation in HBSS  5% (wt/vol)
BSA; Fluka, Fuchs, Switzerland; c.f. van IJzendoorn et al., 1997)] (Figure 1, step
3), and BC-associated lipid analog was chased into SAC at 18°C for 1 h in back
exchange medium (Figure 1, step 4). Then, the NBD fluorescence at the
exoplasmic BC leaflet was abolished using sodium dithionite (Merck Bio-
sciences, Darmstadt, Germany) at 4°C, leaving the majority of the intracellular
GalCer analog in SAC (Figure 1, step 5; van IJzendoorn and Hoekstra, 1998,
2000). After removal of dithionite by washing, transport from SAC was
examined by incubating in back exchange medium at 37°C (Figure 1, step 6).
To quantitate transport of the lipid analog to and from the BC, the percent-
age of NBD-positive BC was determined as described previously (van IJzen-
doorn et al., 1997; van IJzendoorn and Hoekstra, 1998). Briefly, BC were first
identified by phase contrast illumination and then categorized as NBD-
positive or NBD-negative under epifluorescence illumination. Note that a BC
is categorized as fluorescently labeled, i.e., NBD-positive, when microvilli-like
structures, characteristic of the BC, can be detected that are seemingly fluo-
rescent in the wake of the fluorescence derived from the lipid analog, present
in the apical membrane (van IJzendoorn et al., 1997). Such microvilli-like
structures are typically and readily observed upon gradual photobleaching of
the BC-associated NBD fluorescence.
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Distinct pools of fluorescence are thus discerned at the apical pole of the
cells, present in vesicular structures adjacent to BC, which are defined as
SACs (c.f. van IJzendoorn and Hoekstra, 1998). Together, BC and SAC con-
stitute the bile canalicular pole (BCP) in HepG2 cells (Figure 1). Therefore,
within the BCP region the localization of the fluorescent lipid analog will be
defined as being derived from the BC, SAC, or both. This also provides a
means to describe the movement of the lipid within or out of this region in the
cell (van IJzendoorn and Hoekstra, 1999a). Thus, after loading SAC with lipid
analog and allowing its transport to take place as described above, the
direction of movement of the lipid from or within the BCP region is deter-
mined after a given time, by establishing the distribution of the NBD-labeled
lipid over the various compartments (BC, SAC, or both) that constitute the
BCP, relative to the labeling (i.e., primarily SAC), before starting the chase
(t  0). For this kind of analysis, at least 50 BCP per coverslip were analyzed.
Data are expressed as the mean  SEM of at least four independent experi-
ments, carried out in duplicate, and Student’s t tests were carried out to
determine the statistical significance of the data.
RESULTS
Cell Polarity Development Is Positively Correlated with
p27Kip1 Expression
Well-differentiated human hepatic HepG2 cells have been
successfully used for the study of membrane dynamics and
polarity development in hepatocytes. Apical BC PM do-
mains form between two adjacent cells, as readily visualized
by staining the underlying actin network with fluorescently
labeled phalloidin (van IJzendoorn et al., 1997). As shown in
Figure 2A, HepG2 cells acquire PM polarity in time, as
evidenced by the ratio BC/100 cells, and reach optimal
polarity 3 d after plating (Figure 2A; c.f. van IJzendoorn and
Hoekstra, 2000). Treatment of the cells with dibutyryl (db)
cAMP or the interleukin-6 family cytokine oncostatin M
stimulates polarity development, i.e., apical PM biogenesis
in HepG2 cells (Figure 2A, black bars and gray bars, respec-
tively, c.f. van der Wouden et al., 2002), as evidenced by a
2.4- and 1.5-fold increase in the ratio BC/100 cells at 24 and
48–72 h, respectively, after plating. Similar results were
obtained with other stable cAMP analogs, and the adenylate
Figure 1. Schematic representation of the various steps of the lipid
transport assays. The cell-labeling situation after the corresponding
incubation step is depicted at the right. Cells are incubated with
C6NBD-GalCer at 37°C for 30 min, which allows incorporation of
the probe in the basolateral plasma membrane (step 1) and subse-
quent transcytosis to the apical domain (BC; step 2). Then, the
fraction of the fluorescent lipid probe still residing at the basolateral
PM is depleted by BSA at 4°C twice for 30 min (step 3). The
BC-associated probe is then chased into SAC at 18°C for 1 h in
BSA-containing medium (step 4). The presence of BSA in the me-
dium during this step will prevent reentry of any C6NBD-GalCer
that might arrive basolaterally during the chase. Next, the probe
remaining at the BC is quenched by sodium dithionite (step 5). The
sodium dithionite is removed by extensive washing with ice-cold
HBSS. Occasionally, cells were subsequently incubated with OSM at
4°C for 30 min. Transport of the subapically derived fluorescent
probe can be monitored upon rewarming and incubating the cells at
37°C (step 6).
Figure 2. Cell polarity develop-
ment is positively correlated to
p27Kip1 expression and G1 phase ar-
rest. (A) The ratio BC/100 cells was
determined at different times in cells
cultured on coverslips in normal
culture medium (white bars) or nor-
mal culture medium supplemented
with OSM (gray bars) or dbcAMP
(black bars). (B) Cells were cultured
in medium supplemented or not
with OSM or dbcAMP for different
times. Cells were then lysed, and
p27Kip1 expression was examined
by Western blot. A representative
blot of three independent experi-
ments is shown. (C) Expression lev-
els of p27Kip1 (as depicted in B)
were quantified using Scion Image
software. The percentage of increase
compared with nontreated cells (set
to 100%) of three independent ex-
periments is shown (p 0.05 in Stu-
dent’s t test). (D) Cells were cul-
tured in black bars) for different
times. Twenty-four hours before
analysis, BrdU was included in the
culture medium. Cells were fixed
and stained with anti-BrdU antibod-
ies and the DNA stain Hoechst for
immunofluorescence analysis. Note the decreased incorporation of BrdU in OSM- and dbcAMP-treated cells compared with control cells (p
0.05 in Student’a t test), indicative for inhibited G1-S-phase transition.
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cyclase agonist forskolin, but not with sodium butyrate (data
not shown; c.f. Zegers and Hoekstra, 1997).
Although the process of cell differentiation generally
seems negatively correlated with cellular proliferation, it is
not clear whether cell polarity and proliferation are directly,
e.g., genetically, linked or that one is an indirect by-effect of
the other. We observed that after plating, the expression of
p27Kip1 increases significantly (approximately twofold) dur-
ing the first 48 h, after which it remains at a constant level
(Figure 2, B and C, white bars). p27Kip1 plays a critical role in
mediating cell cycle exit by inhibiting the activity of cyclinE/
cdk2, a kinase that is required for the transition of cells from
the G1 phase, i.e., the gap between mitosis and the next
round of DNA synthesis, into S phase. In agreement with the
observed increase in p27Kip1 expression, the number of cells
that enter S phase and start DNA synthesis is reduced, as
evidenced by a decreased incorporation of the thymidine
analog BrdU (Figure 2D). Treatment of the cells with on-
costatin M (10 ng/ml) enhances the increase in p27Kip1 ex-
pression during the first 48 h (Figure 2, B and C, gray bars)
and results in a more pronounced arrest in the G1 phase
(Figure 2D, gray bars). Similar results were obtained with
dibutyryl cAMP (Figure 2, B–D, black bars), well-known to
stimulate cell polarity development (Figure 2A, black bars;
c.f. Zegers et al., 1997; van IJzendoorn and Hoekstra, 1999,
2000), and after serum deprivation (Figure 3). Together,
oncostatin M- and cAMP-stimulated cell polarity, i.e., apical
PM biogenesis, is positively correlated with p27Kip1 expres-
sion and G1-phase arrest.
Down-Regulation of p27Kip1 Expression and Subsequent
S-Phase Entry Inhibits Oncostatin M-stimulated Polarity
Development
We next investigated whether control of G1-S-phase pro-
gression by p27Kip1 is functionally coupled to apical PM
biogenesis. To this end, cells were cultured for 36 h in
normal cell culture medium to allow expansion of the cells,
followed by serum deprivation for another 36 h to synchro-
nize the cells in the G1 phase. Cells were then stimulated
with medium supplemented with (SS) or without (SD) 10%
FCS and oncostatin M, in the presence of BrdU for 4 h
(Figure 3A). In parallel, cells were grown in normal culture
medium for 76 h without medium refreshment for compar-
ison (control; C). As shown in Figure 3, B and C, serum
deprivation resulted in increased levels of p27Kip1 (1.4-
fold), whereas the subsequent stimulation with serum, but
not buffer, resulted in the marked down-regulation of
p27Kip1 expression (40%). In agreement with this, few cells
entered S phase in serum-deprived cells, whereas, by con-
trast, 70% of the cells (3.5-fold increase) entered S phase
after serum stimulation, as evidenced by a massive BrdU
incorporation (Figure 3D). The mitotic index in serum-stim-
ulated cell cultures was 3% (unpublished data). Impor-
tantly, whereas oncostatin M effectively stimulated cell po-
larity development in serum-deprived cells by 45%, as
evidenced by an increased ratio of apical PM domains per
number of cells, serum-stimulated cells were found to be
completely insensitive to oncostatin M stimulation with re-
spect to apical PM biogenesis (Figure 3E).
Similar effects were observed with hydroxyurea (CH4N2O2).
Hydroxyurea inactivates ribonucleoside reductase, thereby
blocking deoxynucleotide synthesis and arresting the cells in S
phase (Balczon et al., 1995; Khodjakov et al., 2002). HepG2 cells
were cultured for 36 h in normal culture medium to allow
expansion of the cells and then treated with 4 mM hydroxyu-
rea for 36 h, followed by incubation in medium containing
OSM and hydroxyurea for 4 h (Figure 4A). Hydroxyurea
prevented DNA synthesis in HepG2 cells as evidenced by
reduced BrdU incorporation compared with nontreated
cells (73% reduction; c.f. Chouteau et al., 2001). As shown
in Figure 4B, hydroxyurea rendered the cells insensitive to
the polarity-stimulating effects of OSM very similar as
observed in serum-stimulated cells (c.f. Figure 3D).
As an alternative approach to drive cells from G1 into the
S phase, the cells were treated with the mycotoxin fumonisin
B1 (FB1) which, in HepG2 cells, results in a decrease in
p27Kip1 expression of 75% (Figure 5A). As a consequence,
cells treated with FB1 shifted from the G1 to S phase, evi-
denced by an increase in the number of cells that had incor-
porated BrdU (Figure 5A, inset). Treatment of the cells with
FB1 inhibits polarity development (Figure 5B). We then ex-
amined the effect of FB1-mediated down-regulation of
p27Kip1 expression on the ability of oncostatin M to stimulate
apical PM biogenesis. Oncostatin M failed to stimulate po-
larity development in FB1-treated cells (Figure 5B), similarly
as observed in serum-stimulated or hydroxyurea-treated
cells (Figures 3D and 4).
Down-regulation of p27Kip1 expression and subsequent
G1-S-phase transition is typically mediated by the increased
activity of cyclin-dependent kinase (cdk)2. Indeed, when
serum-deprived cells were incubated with the cdk2 inhibitor
roscovitin during subsequent serum or FB1 stimulation, cells
failed to enter S phase, as evidenced by a lack of increased
BrdU incorporation (unpublished data). Importantly, cdk2-
inhibited cells retained their sensitivity to the polarity-stim-
ulating effects of oncostatin M after serum or FB1 stimula-
tion (Figure 5B). These data thus suggest that p27Kip1 down-
regulation by itself is not sufficient but requires cdk2 activity
to render the cells insensitive to the polarity-stimulating
effects of oncostatin M. Conversely, the down-regulation of
cdk2 activity, mediated by OSM-stimulated p27Kip1 expres-
sion, thus seems an important parameter in OSM-stimulated
apical PM biogenesis.
G1-S Phase Transition Pertubs Oncostatin M-regulated
Polarized Membrane Trafficking
In hepatocytes, the SAC, the equivalent of the common
endosome in other epithelial cells (van IJzendoorn and
Hoekstra, 1999b; van IJzendoorn et al., 2000) plays a crucial
role in polarity development. In previous studies, we have
demonstrated that polarity development in HepG2 cells re-
quires the activation of a vesicular trafficking route exiting
SAC and directed toward the developing BC, which can be
monitored by the flow of the fluorescent probes C6-NBD-SM
and C6-NBD-GalCer (van IJzendoorn and Hoekstra, 1999a,b,
2000). Oncostatin M activates this pathway to stimulate api-
cal PM biogenesis (van der Wouden et al., 2002). The ques-
tion thus arises whether up-regulation of p27Kip1 expression
and, consequently, inhibition of G1-S-phase transition, is
required for oncostatin M to exert its effects on membrane
traffic. To investigate this, cells were synchronized using
serum deprivation/stimulation, according to the incubation
scheme depicted in Figure 3A, and SAC was preloaded with
C6-NBD-GalCer as described in detail in Materials and Meth-
ods (c.f. van der Wouden et al., 2002). A scheme depicting the
incubation steps is shown in Figure 1. Note that the traffick-
ing steps necessary for loading SAC, i.e., basolateral endo-
cytosis, apical delivery and apical PM-to-SAC transport,
were not visibly affected by the synchronization procedure
(Figure 6, A and D). After loading of the fluorescent lipid
analogue in SAC, cells were treated with oncostatin M or
medium at 4°C (Figure 1, step 5), warmed to 37°C, and lipid
flow from SAC to either apical (BC) or basolateral membrane
was followed for 20 min in serum-free medium or normal
S.C.D. van IJzendoorn et al.
Molecular Biology of the Cell4108
culture medium (Figure 1, step 6). In control (i.e., serum-
deprived; G1) cells, C6-NBD-GalCer disappeared during this
time interval from the BCP, which comprises SAC (where
the lipid is located at t  0; Figure 6A) and BC. Indeed, the
percentage of BCP that contained C6-NBD-GalCer decreased
in time (Table 1). The relative distribution of the lipid ana-
logue in the remaining, faintly labeled C6-NBD-GalCer-pos-
itive BCP shows that the probe predominantly resided in
SAC and little, if any, movement from SAC to BC could be
detected (Table 1; Figure 6B, compare with 6A). Rather,
these data indicate that the probe was transported from SAC
to the basolateral domain of the cells, consistent with previ-
ous observations (van IJzendoorn and Hoekstra, 1999a,
2000). By contrast, in oncostatin M-treated G1 cells, C6-NBD-
GalCer remained associated with the BCP region during the
20-min chase, as evidenced by the unchanged percentage of
BCP that contained C6-NBD-GalCer (Table 1). Analysis of
the corresponding relative distribution of the probe in the
BCP reveals a flow of the lipid analogue from SAC to BC
(Table 1; Figure 6C, compare to 6B; cf. van IJzendoorn and
Hoekstra, 1999a, 2000). In striking contrast, oncostatin M
failed to target C6-NBD-GalCer from SAC to BC in serum-
Figure 3. Effect of OSM on polarity development in G1- and S-phase HepG2 cells. (A) Scheme depicting how cells are synchronized and
treated with OSM in the G1 and S phase of the cell cycle. (B) Expression levels of p27Kip1 in serum-deprived (SD), serum-stimulated (SS), and
control (C) cells. (C) Quantification of the relative expression levels of p27Kip1 in SD, SS compared with C cells. (D) Relative changes in the
incorporation of BrdU in SD, SS compared with C cells. (E) Effect of OSM on polarity development in SD, SS, and C cells.
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stimulated cells, i.e., cells that had entered S phase (Table 1;
Figure 6F, compare with 6E). Thus, in serum-stimulated
cells, C6-NBD-GalCer remained associated with the BCP
during the 20-min chase (Table 1), and analysis of the rela-
tive distribution of the lipid analogue in the labeled BCP
revealed that most C6-NBD-GalCer localized to SAC (Table
1; Figure 6F), indicating entrapment of the lipid in SAC.
Serum stimulation did not affect transport of the fluorescent
lipid exiting SAC in the basolateral direction (Figure 6, E vs.
B). These data strongly suggest that a minimal level of
p27Kip1 expression, sufficient for G1 arrest, is a prerequisite
for oncostatin M signaling to specifically activate SAC-to-BC
trafficking route and, in this way, to stimulate polarity de-
velopment.
Treatment of the cells with the cdk2 inhibitor roscovitin
shortly before and during serum stimulation, thereby pre-
cluding G1-S phase transition, rescued the ability of OSM to
activate SAC-to-BC route followed by C6-NBD-GalCer (Ta-
ble 1; Figure 6G, compare with 6C and 6F) and, presumably
in this way, apical PM biogenesis (Figure 5), implicating the
involvement of cdk2 activity.
G1-S-Phase Transition Inhibits OSM-stimulated
Recruitment of PKA to the Centrosomal Region
The ability of OSM to activate SAC-to-apical surface route
requires cAMP/PKA activity, as evidenced by using phar-
macological inhibitors of PKA (van der Wouden et al., 2002).
Although OSM did not give rise to increased cAMP or PKA
expression levels, a significant recruitment of PKA to the
centrosome region was noted (van der Wouden et al., 2002).
To determine whether the OSM-stimulated recruitment of
PKA to the centrosome region corresponds to its ability to
activate the SAC-to-BC pathway, we examined the effect of
G1-S-phase transition on the ability of OSM to stimulate
centrosomal PKA recruitment. For this, cells were synchro-
nized in G1 by serum deprivation and subsequently incu-
bated for 4 h in serum-free medium (which maintains the
cells in G1) or in FCS-containing medium (which drives the
cells into the S-phase), both supplemented with OSM. Cells
were then fixed and stained with antibodies raised against
the centrosomal protein -tubulin and PKA. The percentage
of PKA-positive centrosomes (identified by -tubulin) was
then determined. As shown in Table 2, OSM stimulated the
recruitment of PKA to centrosome region in G1 cells (24%
more -tubulin–labeled centrosomes were positive for PKA).
Illustrative immunofluorescence pictures are shown in Fig-
ure 7, A–F. In striking contrast, OSM failed to recruit PKA to
the centrosome region in S-phase cells (Table 2). In fact, 13%
less -tubulin–labeled centrosomes in serum-stimulated
cells displayed PKA association, and OSM failed to stimu-
late PKA recruitment at the centrosomal region (Table 2 and
Figure 7, G–L). In serum-stimulated cells, but not in serum-
deprived cells, some PKA localized to the nucleus. Given
that PKA is required for OSM to activate the SAC-to-BC
transport pathway and apical PM biogenesis, the apparent
inability of OSM to recruit PKA to the centrosome region
upon G1-S-phase transition possibly is part of the underly-
ing mechanism responsible for rendering the cells insensi-
tive to OSM with regard to apical PM biogenesis.
DISCUSSION
In this study, we have addressed the functional relationship
between cell cycle regulation and the acquisition of a polar-
ized phenotype, i.e., apical PM biogenesis, in hepatic HepG2
cells in response to OSM signaling. First, we demonstrate
that (OSM-stimulated) apical PM biogenesis in HepG2 cells
displays a strong positive correlation with expression levels
of the cell cycle regulatory protein p27Kip1 and subsequent
G1-phase arrest. Indeed, exposure of the cells to OSM en-
Figure 4. Effect of hydroxyurea (HU) on OSM-stimulated polarity
development. (A) Scheme depicting how cells are synchronized
with HU (4 mM). (B) HU inhibits the cell polarity-stimulating effects
of OSM.
Figure 5. Effect of FB1 on cell cycle and
OSM-mediated polarity development. (A)
FB1 down-regulates p27Kip1 expression (blot
and quantification) and promotes S-phase
entry, as evidenced by BrdU incorporation
(inset). (B) FB1 inhibits OSM-stimulated po-
larity development in HepG2 cells. Note
that the cdk2 inhibitor roscovitin restores
the stimulatory effect of OSM on polarity
development in FB1-treated cells.
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hances the expression of p27Kip1 and prevents entry of the
cells in S phase as evidenced by the inhibition of BrdU
incorporation (Figure 2). This is in agreement with the find-
ings of Klausen et al. (2000), which showed that OSM inhib-
its cell cycle progression by preventing p27Kip1 degradation
in HepG2 cells. Importantly, our data indicate that apical
PM biogenesis stimulated by OSM is critically dependent on
the ability of OSM to control p27Kip1/cdk2-mediated G1-S-
phase progression. Thus, asynchronous cells readily re-
spond to OSM signaling with regard to apical PM biogene-
sis, and serum deprivation, which results in increased
p27Kip1 expression and synchronization of the cells in G1-
phase, enhances the stimulatory effect of OSM (Figure 3). In
striking contrast, serum- or FB1-stimulated down-regulation
of p27Kip1 expression levels, allowing G1-S-phase transition
to occur, effectively renders the cells insensitive to the cell
polarity-stimulating effects of OSM (Figures 2 and 3). In-
deed, cells similarly acquire insensitivity to the polarity-
stimulating effects of OSM after hydroxyurea-induced S-
phase arrest (Figure 4). p27Kip1 down-regulation results in
an expected net increase in cdk2 activity, which plays an
important role in G1-S-phase transition (Ekholm and Reed,
2000; Woo and Poon, 2003). Inhibition of cdk2 activity in
HepG2 cells with roscovitin prevented G1-S-phase transition
and kept the cells responsive to the polarity-stimulating
effects of OSM, even in the serum- or FB1-treated cells.
Together, our data indicate that extracellular signal- and
p27Kip1/cdk2-regulated cell cycle progression controls de
novo apicalization of the cell surface.
Serum-stimulated G1-S-phase transition effectively inhib-
its the OSM-stimulated and PKA-dependent activation of a
membrane transport pathway exiting the SAC and directed
toward the developing apical surface (Table 1 and Figure 6).
The activation of this membrane trafficking pathway has
previously been demonstrated to play an important role in
apical-basolateral polarity development in HepG2 cells (van
IJzendoorn and Hoekstra, 1999a,b; van IJzendoorn et al.,
2000; Hoekstra et al., 2004). OSM-stimulated membrane traf-
ficking from SAC to the developing apical surface is depen-
dent on intact microtubules (unpublished data). Serum-
stimulated G1-S-phase transition, however, did not visibly
affect the spatial organization of SAC (Figure 6) and also the
distribution of the microtubule cytoskeleton was not visibly
altered (unpublished data), supporting the notion that se-
Figure 6. G1-S-phase transition perturbs OSM-stimulated polarized membrane traffic from SAC. Serum-
deprived cells kept in serum-free medium (G1) or were stimulated with serum (SS; S phase) after which the
SAC was loaded with C6NBD-GalCer as described in detail in Materials and Methods. Note that the fluorescent
probe predominantly labeled the SAC (arrows), whereas no labeling of the BC (asterisk) membrane was
observed. In some experiments (G), cells were then treated with roscovitin (R) for 30 min at 4°C. The
fluorescent probe was subsequently chased from the SAC in serum-free medium (B and C) or medium
supplemented with serum (SS, E–G) in the presence (C, F, and G) or absence (B and E) of OSM for 20 min at
37°C. Note the redistribution of the fluorescent probe from the SAC to the BC membranes in C and G, whereas
no redistribution from SAC to BC could be observed in B, C, and F. Bar, 5 m.











% Positive BCP 89 (2) 63 (4)* 88 (3) 90 (2) 84 (4)
Relative distribution in BCP
SAC 84 (3) 79 (3) 40 (2)* 89 (3) 30 (4)*
BC  SAC 17 (2) 21 (3) 30 (4)* 11 (2) 20 (1)
BC 3 (1) 2 (1) 35 (3)* 3 (1) 45 (3)*
* p  0.05.
Cell Cycle Dynamics Control Cell Polarity Development
Vol. 15, September 2004 4111
rum-stimulated cells had not reached prophase during
which microtubules are rearranged to form spindles, and
indicating that the observed S-phase entry-induced impair-
ment of OSM-regulated polarized membrane traffic from
SAC is not likely the result of a cell cycle-related reorgani-
zation of the microtubule cytoskeleton.
The OSM-stimulated and PKA-dependent reorganization
of polarized membrane trafficking from SAC coincides with
a stimulated recruitment of PKA to the centrosomal region
(van der Wouden et al., 2002). The SAC and other organelles
involved in polarized sorting, e.g., the Golgi apparatus, are
typically concentrated in the centrosomal region (Hobdy-
Henderson et al., 2003; Rios and Bornens, 2003), and both the
centrosome and associated organelles typically face special-
ized cell surface domains, e.g., the leading lamella in migrat-
ing fibroblasts (Ueda et al., 1997) and the apical PM domain
in epithelial cells (Buendia et al., 1990). Moreover, in differ-
entiated G1 cells, one of the centrosomes moves to the apical
surface to form the basal body of the primary cilium, a
highly specialized membrane domain that extends from the
apical surface. The functional relevance for the clustering of
SAC and Golgi around the centrosome is not clear, but it
may serve a purpose in integrating complex signaling cas-
cades (Lange, 2002; Rios and Bornens, 2003). In addition,
recent evidence suggests that the centrosome positions or-
ganelles in proximity to specific target membranes. This may
then facilitate or reinforce cytoskeleton remodeling and/or
membrane exchange between organelles and the cell surface
necessary for the biogenesis of specialized PM domains,
such as the apical surface (Wald et al., 2003) or the furrow
during cytokinesis (Riggs et al., 2003). Serum-triggered G1-
S-phase transition effectively inhibits the OSM-stimulated
recruitment of PKA to the centrosomal region (Table 2 and
Figure 7). This is in agreement with the finding that the
displacement of PKA from centrosomes positively modu-
lates G1-S-phase transition (Feliciello et al., 2000). Interest-
ingly, very similar to the observed inhibition of de novo
polarity development upon G1-S-phase transition (Figures 3
and 4), the stimulatory effect of OSM on apical PM biogen-
esis in HepG2 cells is abolished when cAMP/PKA activity is
inhibited (van der Wouden et al., 2002). These data suggest
that recruitment of PKA to the centrosomal region is re-
quired for OSM to activate a membrane traffic route from
SAC to the developing apical surface, and in this way,
stimulate apical PM biogenesis. This underscores the impor-
tance of the centrosomal region as a specialized site where
complex cellular events, including cell cycle progression and
membrane traffic, are coordinately integrated (Rieder et al.,
Table 2. Effect of serum-stimulated G1-S-phase transition on OSM-




OSM 24  4*
SS-control 13  4*
SS-OSM 12  3*
* p  0.01 (OSM vs. control; SS-control vs. control; SS-OSM vs.
OSM).
SS, serum starved.
Figure 7. Effect of serum-stimulated G1-S-phase transi-
tion on OSM-stimulated recruitment of PKA to the centro-
somal region. Serum-deprived cells were kept in serum-
free medium (to keep them in G1; A–F) or were stimulated
with serum (to drive them in the S phase; G–L) in the
presence (D–F, J–L) or absence (A–C, G–I) of OSM. The
cells were then fixed and labeled with antibodies against
-tubulin and PKA as described in Materials and Methods.
The percentage of -tubulin–positive centrosomes that
were labeled with PKA was determined and representative
pictures were taken. Note that OSM stimulates the recruit-
ment of PKA to -tubulin–positive centrosomes (dotted
appearance) in G1 cells (compare D–F with A–C) but not in
S-phase cells (compare J–L with G–I). Arrows in B and C
point to centrosomes positive for both -tubulin and PKA.
In D–F, all -tubulin–positive centrosomes shown are also
positive for PKA. C, F, I, and L show merged images with
-tubulin in red and PKA in green. Bars, 10 m.
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2001), and it implicates OSM as an important regulating
factor in this. At present, a molecular link between cdk2
activity at the G1/S-boundary and PKA association at the
centrosome is unclear. However, such a link is not unprec-
edented because mitotic CDK1 activity has been demon-
strated to displace PKA from centrosomal A-kinase anchor-
ing proteins. We are currently investigating the molecular
mechanism by which OSM stimulates PKA recruitment to
the centrosomal region and the identification of OSM-con-
trolled PKA targets.
Based on the data, we propose a model (Figure 8) in which
OSM signaling enhances p27Kip1 expression, and conse-
quently down-regulates cdk2 activity, resulting in G1 arrest.
Low cdk2 activity allows OSM-stimulated recruitment of
PKA to the centrosomal region that is essential for mediating
the OSM-activated membrane exchanges between SAC and
the developing apical surface. On G1-S-phase transition, in-
duced by circulating growth factors or mitogenic mycotox-
ins such as FB1 (Schroeder et al., 1994; this study), the
increasing cdk2 activity may not be sufficiently down-regu-
lated by OSM and therefore interferes with OSM-mediated
recruitment of PKA to the centrosomal region. This then
impairs the regulated membrane supply from the pericen-
trosomal SAC to the cell surface and hence apical PM bio-
genesis. This model underscores the recently suggested role
of endosomal recycling in the spatial-temporal control of
plasma membrane insertion that is required for cell morpho-
genesis (Lecuit, 2003; Pelissier et al., 2003), e.g., the develop-
ment of the apical domain, and it places PKA-regulated
polarized plasma membrane recycling under control of
p27Kip1/cdk2-regulated G1-S-phase transition.
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